In Vitro Susceptibility of Aztreonam-Vaborbactam, Aztreonam-Relebactam and Aztreonam-Avibactam Associations against Metallo-β-Lactamase-Producing Gram-Negative Bacteria

Background: Despite the availability of new options (ceftazidime-avibactam, imipenem-relebactam, meropenem-vaborbactam and cefiderocol), it is still very difficult to treat infections caused by metallo-β-lactamase (MBLs)-producers resistant to aztreonam. The in vitro efficacy of aztreonam in associa...

Full description

Bibliographic Details
Published in:Antibiotics
Main Authors: Cécile Emeraud, Sandrine Bernabeu, Laurent Dortet
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Subjects:
Online Access:https://www.mdpi.com/2079-6382/12/10/1493